Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions

Amjad H. Jawad*, Mufeed J. Ewadh, Rebee M. Hasani.




Abstract

A case-control study include 60 patients with beta-thalassemia major type with recurrent blood transfusion were visited
Babylon center of hereditary blood disorder in Babylon teaching hospital for maternity and children and 60 individuals
who seemed to be healthy. This study aimed to assess N-acetyl-beta-glucosaminidase and others renal function and
to look for renal complications in those patients if any. These patients and control groups divided into two subgroups
according to age, group I were less than 18 year and group II were equal or more than 18 years. The present study’s
findings showed that there was a significant difference in the levels of Albumin to creatinine ratio, Beta2-microglobulin,
N-Acetyl beta-D-glucosaminidase, serum creatinine level, and blood urea between patients group and its healthy group
(p < 0.05). In conclusion, beta-thalassemia major patients frequently have renal hemosiderosis and asymptomatic renal
impairment, which are not found in routine renal investigations, it needs regular checks for early detection of tubular
and glomerular failure

Key words: Beta 2 microglobulin ACR NAG,Renal hemosiderosis,Thalassemia major






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.